期刊文献+

野生型p53基因cDNA转染对卵巢癌细胞系SKOV-3生物学行为的影响 被引量:7

Biologic Effects of Introduction of WildType p53 cDNA into a Human Ovarian Cancer Cell Line SKOV3
原文传递
导出
摘要 目的:研究野生型p53基因cDNA转染对卵巢癌细胞系SKOV-3生物学行为的影响。方法:用脂质体介导的转染技术,将含有全长人野生型p53cDNA的真核表达重组质粒和空载体质粒,分别导入不表达p53的SKOV-3细胞,观察细胞生物学行为的改变。结果:(1)共获2个p53cDNA转染克隆(pC53)和2个空载体转染克隆(pNeo);(2)pC53和pNeo细胞形态学与SKOV-3无显著差别;(3)pC53细胞生长明显比SKOV-3慢,而pNeo细胞生长与SKOV-3相当;(4)pC53在软琼脂中形成集落数显著少于SKOV-3细胞和pNeo细胞;(5)pC53G1/G0期细胞百分比高于SKOV-3和pNeo。结论:野生型p53cDNA可作为卵巢癌基因治疗的目的基因之一。 Objective: To study the effects on biologic behavior in cells obtained from human ovarian cancer cell line SKOV3 into which the wildtype p53 cDNA was introduced. Method: Recombinant eukaryotic expression vector pC53SN3 containing fulllength human wildtype p53 cDNA and vector containing neomycin resistance gene only were introduced by lipofectaminemediated gene transfection into SKOV3 cell line which does not express endogenous p53. The clones obtained were observed for their biologic behavior. Results: (1) 2 clones named pC53 and 2 clones named pNeo were obtained after pC53SN3 and vector transfection respectively; (2) The morphology of cells either from pC53 or from pNeo did not change significantly with respect to their parental SKOV3; (3) The growth rate of cells from pC53 was much slower than that from SKOV3, while the cell growth curve of pNeo was similar to that of SKOV3; (4) The number of colones formed in the softagar by pC53 was significantly less than that by SKOV3 or by pNeo; (5) The percentage of phase G1/G0 of pC53 was much higher than that of SKOV3 and pNeo. Conclusion: Wildtype p53 cDNA may be considered as one of the target genes for the gene therapy of ovarian cancer.
出处 《中华妇产科杂志》 CAS CSCD 北大核心 1997年第12期715-717,共3页 Chinese Journal of Obstetrics and Gynecology
关键词 卵巢肿瘤 P53基因 基因转染 SKOV-3 Ovarian neoplasms Gene p53 Transfection
  • 相关文献

参考文献3

  • 1尤宗兵,中华妇产科杂志,1996年,31卷,660页
  • 2鄂征,组织培养和分子细胞学技术,1995年,157页
  • 3卢圣栋,现代分子生物学实验技术,1993年,403页

同被引文献31

  • 1陈波洁.P53基因在卵巢癌中的研究进展[J].国外医学(妇产科学分册),1996,23(4):208-210. 被引量:2
  • 2徐海耿.P53蛋白表达在上皮性卵巢癌中的临床意义[J].临床医学,2006,26(6):82-83. 被引量:3
  • 3萨姆克鲁克 等 金冬雁等(译).分子克隆实验指南,第二版[M].北京:科学出版社,1998.19.
  • 4Perkins ND. NF-kappa promoter B:tumor promoter or suppressor[J]. Trends Cell Biol,2004,14(2): 64-69.
  • 5Chinni SR, Li Y, Upadhyay ,S, et al. Indole3-carbinol (13c) induced cell growth inhibition,G1 cell cycle arrest and apoptosis prostate cancer cells [J]. Oncogene, 2001, 20 (23) : 2927-2923.
  • 6Natoli G ,Chiocca S. Nuclear ubiquitin ligases , NF-kB degradation, and the control of inflammstion [J]. Sci Signal, 2008,1 (1) : pel.
  • 7Jeong SJ , Pise-Masison CA, Radonovich MF, et al. A novel NF-kB pathwayinvoleing IKK and P65/RelA Ser- 536 phosphorylation results in P53 inhibition in the absence of NF-kB transcriptional activity[J]. J Biol Chem ,2005,280(11):10326-10332.
  • 8Hayden MS, Ghosh S. Principles in NF-kB signaling[J]. Cell, 2008,132 (3) : 344-362.
  • 9Marx J. How p53 suppresses cell growth [J ]. Science, 1993,262: 1644-1645.
  • 10Hollstein M, Sidransky D, Vogelsein B, et al. p53 mutations in human cancers [J]. Science (Washington DC), 1991, 253:49-53.

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部